Patient-Reported Outcomes (Pros) In Men With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) And Homologous Recombination Repair (Hrr) Mutations Receiving Talazoparib (Tala) + Enzalutamide (Enza) Vs Placebo (Pbo) + Enza: Results From A Phase III (Talapro-2) Study
Enzalutamide;Talazoparib;Enzalutamide
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Patient-Reported Outcomes (Pros) In Men With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) And Homologous Recombination Repair (Hrr) Mutations Receiving Talazoparib (Tala) + Enzalutamide (Enza) Vs Placebo (Pbo) + Enza: Results From A Phase III (Talapro-2) Study ### Output: Enzalutamide;Talazoparib;Enzalutamide